Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter

Drug Metabolism and Pharmacokinetics

Volumn 29, Issue 5, 2014, Pages 367-372

  Kissei, Maika ^a   Itoh, Tomoo ^a   Narawa, Tomoya ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Catechin; Epigallocatechin gallate; Folic acid; Methotrexate; PCFT

Indexed keywords

EPIGALLOCATECHIN GALLATE; FOLIC ACID; METHOTREXATE; PROTON COUPLED FOLATE TRANSPORTER; CATECHIN;

ARTICLE; CACO 2 CELL LINE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG TRANSPORT; FOLATE METABOLISM; FOLIC ACID TRANSPORT; FOOD DRUG INTERACTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; INTESTINE ABSORPTION; MICHAELIS MENTEN KINETICS; PROTEIN EXPRESSION; TEA; ANALOGS AND DERIVATIVES; CELL CULTURE; CHEMISTRY; METABOLISM;

CACO-2 CELLS; CATECHIN; CELLS, CULTURED; FOLIC ACID; HEK293 CELLS; HUMANS; METHOTREXATE; PROTON-COUPLED FOLATE TRANSPORTER;

EID: 84908234369     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-14-RG-015     Document Type: Article

References (45)

1. Lucock, M.: Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab., 71: 121-138 (2000).
2. Stover, P. J.: Physiology of folate and vitamin B12 in health and disease. Nutr. Rev., 62: S3-S12 (2004).
3. Said, H. M.: Intestinal absorption of water-soluble vitamins in health and disease. Biochem. J., 437: 357-372 (2011).
4. +-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp. Physiol., 92: 603-619 (2007).
5. Sirotnak, F. M. and Tolner, B.: Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr., 19: 91-122 (1999).
6. Matherly, L. H. and Goldman, I. D.: Membrane transport of folates. Vitam. Horm., 66: 403-456 (2003).
7. Qiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., et al.: Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell, 127: 917-928 (2006).
8. Zhao, R., Matherly, L. H. and Goldman, I. D.: Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev. Mol. Med., 11: e4 (2009).
9. Nguyen, T. T., Dyer, D. L., Dunning, D. D., Rubin, S. A., Grant, K. E. and Said, H. M.: Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology, 112: 783-791 (1997).
10. Dixon, K. H., Lanpher, B. C., Chiu, J., Kelley, K. and Cowan, K. H.: A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem., 269: 17-20 (1994).
11. Moscow, J. A., Gong, M., He, R., Sgagias, M. K., Dixon, K. H., Anzick, S. L., Meltzer, P. S. and Cowan, K. H.: Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res., 55: 3790-3794 (1995).
12. Prasad, P. D., Ramamoorthy, S., Leibach, F. H. and Ganapathy, V.: Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun., 206: 681-687 (1995).
13. Williams, F. M. R., Murray, R. C., Underhill, T. M. and Flintoff, W. F.: Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J. Biol. Chem., 269: 5810-5816 (1994).
14. Williams, F. M. R. and Flintoff, W. F.: Isolation of human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol. Chem., 270: 2987-2992 (1995).
15. Wong, S. C., Proefke, S. A., Bhushan, A. and Matherly, L. H.: Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J. Biol. Chem., 270: 17468-17475 (1995).
16. Wang, Y., Zhao, R. and Goldman, I. D.: Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin. Cancer Res., 10: 6256-6264 (2004).
17. Geller, J., Kronn, D., Jayabose, S. and Sandoval, C.: Hereditary folate malabsorption: family report and review of the literature. Medicine, 81: 51-68 (2002).
18. Zhao, R., Min, S. H., Qiu, A., Sakaris, A., Goldberg, G. L., Sandoval, C., Malatack, J. J., Rosenblatt, D. S. and Goldman, I. D.: The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood, 110: 1147-1152 (2007).
19. Lasry, I., Berman, B., Straussberg, R., Sofer, Y., Bessler, H., Sharkia, M., Glaser, F., Jansen, G., Drori, S., et al.: A novel loss of function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function. Blood, 112: 2055-2061 (2008).
20. Alemdaroglu, N. C., Dietz, U., Wolffram, S., Spahn-Langguth, H. and Langguth, P.: Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm. Drug Dispos., 29: 335-348 (2008).
21. Lemos, C., Peters, G. J., Jansen, G., Martel, F. and Calhau, C.: Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur. J. Nutr., 46: 329-336 (2007).
22. Alemdaroglu, N. C., Wolffram, S., Boissel, J. P., Closs, E., Spahn-Langguth, H. and Langguth, P.: Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells. Planta Med., 73: 27-32 (2007).
23. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D., Minutti, R. R., Wang, H., Go, V. L. and Heber, D.: Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr., 80: 1558-1564 (2004).
24. Li, Y. H., Ito, K., Tsuda, Y., Kohda, R., Yamada, H. and Itoh, T.: Mechanism of intestinal absorption of an orally active β-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. J. Pharmacol. Exp. Ther., 290: 958-964 (1999).
25. Narawa, T. and Itoh, T.: Stereoselective transport of amethopterin enantiomers by the proton-coupled folate transporter. Drug Metab. Pharmacokinet., 25: 283-289 (2010).
26. Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T.: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn., 4: 879-885 (1981).
27. Hendel, J. and Brodthagen, H.: Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker. Eur. J. Clin. Pharmacol., 26: 103-107 (1984).
28. Maubon, N., Le Vee, M., Fossati, L., Audry, M., Le Ferrec, E., Bolze, S. and Fardel, O.: Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam. Clin. Pharmacol., 21: 659-663 (2007).
29. Endter, S., Francombe, D., Ehrhardt, C. and Gumbleton, M.: RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epitherial cell models. J. Pharm. Pharmacol., 61: 583-591 (2009).
30. Latunde-Dada, G. O., Takeuchi, K., Simpson, R. J. and Mckie, A. T.: Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells. FEBS Lett., 580: 6865-6870 (2006).
31. Subramanian, V. S., Chatterjee, N. and Said, H. M.: Folate uptake in the human intestine: promoter activity and effect of folate deficiency. J. Cell. Physiol., 196: 403-408 (2003).
32. Narawa, T., Tsuda, Y. and Itoh, T.: Chiral recognition of amethopterin enantiomers by the reduced folate carrier in Caco-2 cells. Drug Metab. Pharmacokinet., 22: 33-40 (2007).
33. Nakai, Y., Inoue, K., Abe, N., Hatakeyama, M., Ohta, K., Otagiri, M., Hayashi, Y. and Yuasa, H.: Functional characterization of human PCFT/HCP1 heterologously expressed in mammalian cells as a folate transporter. J. Pharmacol. Exp. Ther., 322: 469-476 (2007).
34. Narawa, T., Shimizu, R., Takano, S., Tsuda, Y., Ono, K., Yamada, H. and Itoh, T.: Stereoselectivity of the reduced folate carrier in Caco-2 cells. Chirality, 17: 444-449 (2005).
35. Zhao, R., Gao, F., Wang, Y., Diaz, G. A., Gelb, B. D. and Goldman, I. D.: Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J. Biol. Chem., 276: 1114-1118 (2001).
36. Zhao, R., Gao, F. and Goldman, I. D.: Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells. Am. J. Physiol. Cell Physiol., 282: C1512-C1517 (2002).
37. Jin, Y., Jin, C. H. and Row, K. H.: Separation of catechin compounds from different teas. Biotechnol. J., 1: 209-213 (2006).
38. Khokhar, S. and Maqnusdottir, S. G.: Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom. J. Agric. Food Chem., 50: 565-570 (2002).
39. Tachibana, T., Kato, M., Watanabe, T., Mitsui, T. and Sugiyama, Y.: Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein. Xenobiotica, 39: 430-443 (2009).
40. Dresser, G. K., Bailey, D. G., Leake, B. F., Schwarz, U. I., Dawson, P. A., Freeman, D. J. and Kim, R. B.: Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther., 71: 11-20 (2002).
41. Imanaga, J., Kotegawa, T., Imai, H., Tsutsumi, K., Yoshizato, T., Ohyama, T., Shirasaka, Y., Tamai, I., Tateishi, T., et al.: The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet. Genomics, 21: 84-93 (2011).
42. Shirasaka, Y., Shichiri, M., Mori, T., Nakanishi, T. and Tamai, I.: Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J. Pharm. Sci., 102: 280-288 (2013).
43. Roth, M., Timmermann, B. N. and Hagenbuch, B.: Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab. Dispos., 39: 920-926 (2011).
44. Annaba, F., Kumar, P., Dudeja, A. K., Saksena, S., Gill, R. K. and Alrefai, W. A.: Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT. Am. J. Physiol. Gastrointest. Liver Physiol., 298: G467-G473 (2010).
45. Zhang, S., Yang, X. and Morris, M. E.: Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol., 65: 1208-1216 (2004).